---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-127798"
form_type: "8-K"
ticker: "GANX"
cik: "0001819411"
company_name: "Gain Therapeutics, Inc."
filed_at: "2022-12-16T23:59:59+00:00"
generated_at: "2026-06-21T03:32:28.821212+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Gain Therapeutics appoints Gianluca Fuggetta as Principal Accounting Officer

## Summary
- Gianluca Fuggetta, Finance Director Corporate Reporting since July 2022, appointed Principal Accounting Officer effective Dec 12, 2022.
- Prior to Gain Therapeutics, Fuggetta spent nearly 9 years at PricewaterhouseCoopers, most recently as Assurance Manager.
- CFO Salvatore Calabrese, who previously served as both Principal Financial and Accounting Officer, will continue as Principal Financial Officer.

## SEC filing metadata
- accession: 0001104659-22-127798
- form_type: 8-K
- ticker: GANX
- cik: 0001819411
- company_name: Gain Therapeutics, Inc.
- filed_at: 2022-12-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819411/000110465922127798/0001104659-22-127798-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819411/000110465922127798/tm2232896d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-127798
- JSON: https://secwatch.observer/filing/0001104659-22-127798.json
- Plain text: https://secwatch.observer/filing/0001104659-22-127798.txt

## Key facts
- Executive change
  Salvatore Calabrese changed role as Principal Accounting Officer at Gain Therapeutics, Inc..
  - Role: Principal Accounting Officer
  source text: The Company’s Chief Financial Officer, Salvatore Calabrese, who was previously serving as both Principal Financial Officer and Principal Accounting Officer, will continue serving as the Company's Principal Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819411/000110465922127798/0001104659-22-127798-index.htm
- Executive change
  Gianluca Fuggetta was appointed as Principal Accounting Officer at Gain Therapeutics, Inc..
  - Action: appointed
  - Role: Principal Accounting Officer
  source text: On December 12, 2022, Gain Therapeutics, Inc. (the " Company ") appointed Gianluca Fuggetta, its Finance Director, Corporate Reporting, as the Company's Principal Accounting Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819411/000110465922127798/0001104659-22-127798-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.